Mesoscopic studies on toxic effect of doxorubicin on rat cardiac muscles
by Osama A.H. Abu-Zinadah, Salim M. El-Hamidy, Nevine Abdel Azim Refaat
International Journal of Nano and Biomaterials (IJNBM), Vol. 2, No. 1/2/3/4/5, 2009

Abstract: The anthracycline antibiotic doxorubicin (DOX) is one of the most effective anti-tumour agents used to treat human malignancies. Long-term treatment with DOX is limited by its cardiotoxicity. The purpose of the present study was to evaluate the cardiotoxic effect of DOX using nanoscale. Twelve adult male rats were divided into two groups: control group, group 2A, DOX one week (DOX 1wk), group2B, DOX two weeks (DOX 2wk). Ultrastructural damage using mesoscopic studies showed cardiomyocytes injury after one week and more pronounced after two weeks by increase in thickness of thick myosin filaments (22 nm to 25 nm) and widening of interfilaments spaces (4 nm to 8 nm). In addition to the changes in the mitochondria being the most extensively and progressively injured organelle such as swelling, disorganisation of cristae, vacuolisation to degeneration and complete loss of mitochondrial cristae. The thickness of cristae measured by mesoscopic scale range from 25 nm to 31 nm and spaces vary between 22 nm to 28 nm especially after two weeks of DOX injection.

Online publication date: Sat, 08-Aug-2009

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nano and Biomaterials (IJNBM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com